RECRUITING

Collaborative Care for Anxiety and Depression in Epilepsy

Talk to us

Conditions

EpilepsyAnxietyDepressionQuality of LifeCollaborative care

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a randomized effectiveness/implementation trial comparing a 24-week neurology-based collaborative care intervention to usual neurology care among 60 adults with epilepsy.

Official Title

Collaborative Care to Improve Quality of Life for Anxiety and Depression in Epilepsy

Quick Facts

Study Start:2023-05-04
Study Completion:2025-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05559749

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Provision of signed and dated Informed Consent Form
  2. * Stated willingness to comply with all study procedures
  3. * Males and Females; Age \>= 18 years
  4. * \* Diagnosis of epilepsy: Epilepsy diagnosis based on neurology clinician impression or EEG findings
  5. * Anxiety or Depression symptoms
  6. * Receiving clinical neurological care at Atrium Health
  1. * Current participation in another treatment of intervention study
  2. * Cognitive limitations precluding completion of Anxiety and Depression self-report instruments on paper, electronically, or by interview
  3. * Comorbid medical condition with life expectancy less than 6 months
  4. * Not a good candidate for collaborative care due to:
  5. * Active ongoing treatment by a psychiatrist
  6. * Active suicidal ideation
  7. * History of past suicide attempt and:
  8. * receiving ongoing psychotherapy OR
  9. * has seen a psychiatrist in the past year
  10. * History of suicide attempt in the past year and:
  11. * currently prescribed 2 or more psychotropic medications for psychiatric indication (not merely as a hypnotic) AND not felt to be a good candidate for collaborative care based on the judgement of the investigators
  12. * Unstable drug or alcohol abuse
  13. * individuals who meet the above INC-EXC criteria and have completed the Control Arm of a collaborative care research study - NCT05559749 - NCT05353452 or
  14. * individuals who meet the above INC-EXC criteria except rather than having a diagnosis of Epilepsy; they have a diagnosis of functional neurological disorder with seizures

Contacts and Locations

Study Contact

Lauren P Richmond
CONTACT
336.716.9632
lprichmo@wakehealth.edu
Heidi M Munger Clary, MD, MPH
CONTACT
336-716-7110
hmungerc@wakehealth.edu

Principal Investigator

Heidi M Munger Clary, MPH
PRINCIPAL_INVESTIGATOR
Wake Forest University Health Sciences

Study Locations (Sites)

Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157
United States

Collaborators and Investigators

Sponsor: Wake Forest University Health Sciences

  • Heidi M Munger Clary, MPH, PRINCIPAL_INVESTIGATOR, Wake Forest University Health Sciences

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-05-04
Study Completion Date2025-03

Study Record Updates

Study Start Date2023-05-04
Study Completion Date2025-03

Terms related to this study

Keywords Provided by Researchers

  • Quality of Life
  • Collaborative care

Additional Relevant MeSH Terms

  • Epilepsy
  • Anxiety
  • Depression